Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

COLLEGIUM PHARMACEUTICAL, INC Director's Dealing 2025

Nov 14, 2025

32163_dirs_2025-11-14_58c0a362-a8f7-4bf6-b731-792b9836f77f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: COLLEGIUM PHARMACEUTICAL, INC (COLL)
CIK: 0001267565
Period of Report: 2025-11-12

Reporting Person: Karnani Vikram (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-11-12 Common Stock F 8983 $47.35 Disposed 96989 Direct

Footnotes

F1: Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of restricted stock units.